Progesterone
- PMID: 30000404
- Bookshelf ID: NBK501345
Progesterone
Excerpt
Because of the low reported levels of progesterone in breastmilk, even with the high-dose products, amounts ingested by the infant are small and would not be expected to cause any adverse effects in breastfed infants. The progesterone vaginal ring available outside the US produces maternal blood levels that are lower than those of ovulating women. Expert opinion holds that the risks of progestin-only contraceptive products usually are acceptable for nursing mothers at any time postpartum.[1,2]
In Russia, a progesterone gel (Progestogel, Besins Healthcare; not available in the US) has been used topically as a one-time application to the breasts to treat postpartum breast engorgement when more conservative measures have failed.[3] A subsequent study failed to detect any decrease in breast hardness 20 minutes after application of progesterone gel in mothers with engorgement.[4] The safety and efficacy of this use have not been well studied and the manufacturer of Progestogel recommends avoiding its use during lactation.
References
-
- World Health Organization. Medical Eligibility Criteria For Contraceptive Use: Sixth Ed. 2025. https://www.who.int/publications/i/item/9789240115583 - PubMed
-
- Pustotina O. Management of mastitis and breast engorgement in breastfeeding women. J Matern Fetal Neonatal Med 2016;29:3121–5. - PubMed
-
- Alekseev NP. Progesterone-containing gel does not eliminate postpartum breast engorgement? Breastfeed Med 2017;12:122–3. - PubMed
-
- Croxatto HB, Díaz S. The place of progesterone in human contraception. J Steroid Biochem 1987;27:991–4. - PubMed
Publication types
LinkOut - more resources
Full Text Sources